Severe osteopenia in CFTR-null mice

Bone

Volumn 35, Issue 3, 2004, Pages 595-603

  Dif, Fariel ^a   Marty, Caroline ^b   Baudoin, Claude ^b   De Vernejoul, Marie Christine ^b   Levi, Giovanni ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b CENTRE VIGGO PETERSEN   (France)

Author keywords

Bone; CFTR; Cystic fibrosis; Mutant mice; Osteoporosis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICAL BONE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE ACTIVATION; GENE MUTATION; MORPHOMETRICS; MOUSE; NONHUMAN; NUTRITION; OSSIFICATION; OSTEOPENIA; TRABECULAR BONE;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE SILENCING; MICE; MICE, INBRED CFTR; MICE, KNOCKOUT; OSTEOPOROSIS;

EID: 4344707707     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.05.021     Document Type: Article

References (50)

1. Collins F.S. Cystic fibrosis: molecular biology and therapeutic implications. Science. 256:1992;774-779
2. Kerem B., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 245:1989;1073-1080
3. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1989;1066-1073
4. Anderson M.P., Gregory R.J., Thompson S., Souza D.W., Paul S., Mulligan R.C., et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 253:1991;202-205
5. Li M., McCann J.D., Anderson M.P., Clancy J.P., Liedtke C.M., Nairn A.C., et al. Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epithelia. Science. 244:1989;1353-1356
6. Anderson M.P., Berger H.A., Rich D.P., Gregory R.J., Smith A.E., Welsh M.J. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell. 67:1991;775-784
7. Gray M.A., Plant S., Argent B.E. cAMP-regulated whole cell chloride currents in pancreatic duct cells. Am. J. Physiol. 264:1993;C591-C602
8. Clarke L.L., Grubb B.R., Gabriel S.E., Smithies O., Koller B.H., Boucher R.C. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science. 257:1992;1125-1128
9. Welsh M.J., Tsui L.C., BT F., BA L. Cystic fibrosis. SC R., BA L., SW S., V D., FD S. Metabolic and molecular basis of inherited disease. 2000;2649-2680 McGraw-Hill, New York
10. Aris R.M., Lester G.E., Ontjes D.A. Bone loss physiology in critically ill patients. Chest. 114:1998;954-955
11. Bachrach L.K., Loutit C.W., Moss R.B. Osteopenia in adults with cystic fibrosis. Am. J. Med. 96:1994;27-34
12. Bhudhikanok G.S., Lim J., Marcus R., Harkins A., Moss R.B., Bachrach L.K. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics. 97:1996;103-111
13. Gibbens D.T., Gilsanz V., Boechat M.I., Dufer D., Carlson M.E., Wang C.I. Osteoporosis in cystic fibrosis. J. Pediatr. 113:1988;295-300
14. Haworth C.S., Selby P.L., Webb A.K., Dodd M.E., Musson H., Mc L.N.R., et al. Low bone mineral density in adults with cystic fibrosis. Thorax. 54:1999;961-967
15. Laursen E.M., Molgaard C., Michaelsen K.F., Koch C., Muller J. Bone mineral status in 134 patients with cystic fibrosis. Arch. Dis. Child. 81:1999;235-240
16. Grey A.B., Ames R.W., Matthews R.D., Reid I.R. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax. 48:1993;589-593
17. Aris R.M., Renner J.B., Winders A.D., Buell H.E., Riggs D.B., Lester G.E., et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann. Intern. Med. 128:1998;186-193
18. Haworth C.S., Freemont A.J., Webb A.K., Dodd M.E., Selby P.L., Mawer E.B., et al. Hip fracture and bone histomorphometry in a young adult with cystic fibrosis. Eur. Respir. J. 14:1999;478-479
19. Lim J.J., MR B., P J., HE A., BL K. Bone mineral status in cystic fibrosis: risk factors for osteopenia. Pediatr. Pulmonol. 9:1993;278A
20. Bhudhikanok G.S., Wang M.C., Marcus R., Harkins A., Moss R.B., Bachrach L.K. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J. Pediatr. 133:1998;18-27
21. Henderson R.C., Madsen C.D. Bone density in children and adolescents with cystic fibrosis. J. Pediatr. 128:1996;28-34
22. Aris R.M., Neuringer I.P., Weiner M.A., Egan T.M., Ontjes D. Severe osteoporosis before and after lung transplantation. Chest. 109:1996;1176-1183
23. Egan T.M., Detterbeck F.C., Mill M.R., Gott K.K., Rea J.B., McSweeney J., et al. Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group. Ann. Thorac. Surg. 66:1998;337-346
24. Shane E., Silverberg S.J., Donovan D., Papadopoulos A., Staron R.B., Addesso V., et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am. J. Med. 101:1996;262-269
25. Lapey A., Kattwinkel J., Di Sant'Agnese P.A., Laster L. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. J. Pediatr. 84:1974;328-334
26. Ott S.M., Aitken M.L. Osteoporosis in patients with cystic fibrosis. Clin. Chest Med. 19:1998;555-567
27. Koller B.H., Kim H.S., Latour A.M., Brigman K., Boucher R.C. Jr., Scambler P., et al. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10730-10734
28. Vignery A., Baron R. Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat. Rec. 196:1980;191-200
29. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 2:1987;595-610
30. Collins F.S., Wilson J.M. Cystic fibrosis. A welcome animal model. Nature. 358:1992;708-709
31. Snouwaert J.N., Brigman K.K., Latour A.M., Malouf N.N., Boucher R.C., Smithies O., et al. An animal model for cystic fibrosis made by gene targeting. Science. 257:1992;1083-1088
32. Zeiher B.G., Eichwald E., Zabner J., Smith J.J., Puga A.P., McCray P.B. Jr., et al. A mouse model for the delta F508 allele of cystic fibrosis. J. Clin. Invest. 96:1995;2051-2064
33. Kent G., Iles R., Bear C.E., Huan L.J., Griesenbach U., McKerlie C., et al. Lung disease in mice with cystic fibrosis. J. Clin. Invest. 100:1997;3060-3069
34. Hardin D.S., Arumugam R., Seilheimer D.K., LeBlanc A., Ellis K.J. Normal bone mineral density in cystic fibrosis. Arch. Dis. Child. 84:2001;363-368
35. Haworth C.S., Selby P.L., Webb A.K., Adams J.E. Osteoporosis in adults with cystic fibrosis. J.R. Soc. Med. 91:1998;14-18
36. Shaw N., Bedford C., Heaf D., Carty H., Dutton J. Osteopenia in adults with cystic fibrosis. Am. J. Med. 99:1995;690-692
37. Baroncelli G.I., De Luca F., Magazzu G., Arrigo T., Sferlazzas C., Catena C., et al. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr. Res. 41:1997;397-403
38. Abe E., Marians R.C., Yu W., Wu X.B., Ando T., Li Y., et al. TSH is a negative regulator of skeletal remodeling. Cell. 115:2003;151-162
39. Devuyst O., Golstein P.E., Sanches M.V., Piontek K., Wilson P.D., Guggino W.B., et al. Expression of CFTR in human and bovine thyroid epithelium. Am. J. Physiol. 272:1997;C1299-C1308
40. Knopfle G. The thyroid hormone system in mucoviscidosis. Klin. Padiatr. 197:1985;481-488
41. Segall-Blank M., Vagenakis A.G., Shwachman H., Ingbar S.H., Braverman L.E. Thyroid gland function and pituitary TSH reserve in patients with cystic fibrosis. J. Pediatr. 98:1981;218-222
42. Chesnoy-Marchais D., Fritsch J. Chloride current activated by cyclic AMP and parathyroid hormone in rat osteoblasts. Pflugers Arch. 415:1989;104-114
43. Greer R.M., Buntain H.M., Potter J.M., Wainwright C.E., Wong J.C., O'Rourke P.K., et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporos. Int. 14:2003;404-411
44. Clement-Lacroix P., Ormandy C., Lepescheux L., Ammann P., Damotte D., Goffin V., et al. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology. 140:1999;96-105
45. Sims N.A., Clement-Lacroix P., Da Ponte F., Bouali Y, Binart N., Moriggl R., et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 106:2000;1095-1103
46. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 100:2000;197-207
47. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 111:2002;305-317
48. Weyler R.T., Yurko-Mauro K.A., Rubenstein R., Kollen W.J., Reenstra W., Altschuler S.M., et al. CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am. J. Physiol. 277:1999;C563-C571
49. Leifke E., Friemert M., Heilmann M., Puvogel N., Smaczny C., von zur Muhlen A., et al. Sex steroids and body composition in men with cystic fibrosis. Eur. J. Endocrinol. 148:2003;551-557
50. Kolta S., De Vernejoul M.C., Meneton P., Fechtenbaum J., Roux C. Bone mineral measurements in mice: comparison of two devices. J. Clin. Densitom. 6:2003;251-258